EUVIMEDEUVIMED entdecken
Crossref

YTHDF3 facilitates DNA damage response by recognizing METTL3-mediated m6A modification to promote chemotherapy resistance in glioblastoma

Meng Cheng, Ying Pang, Rui Wang, Xu Chen, Chunyu Zhang, Yuntong Yang, Tongjie Ji, Yueyao Wu, Jingzhe Wang, Siyi Xu, Zhigang Wang, Min Liu und 2 weitere

Cancer Letters · 2026-07 · 649 · 218445

DOI: 10.1016/j.canlet.2026.218445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026-07. Verfasst von Meng Cheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China. Hauptthemen laut MEDLINE: Glioblastoma, RNA-Binding Proteins, Methyltransferases, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Shanghai Key Discipline Construction Project, Natural Science Foundation of Shanghai Municipality, Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) poses a formidable challenge in the field of oncology because of its pronounced resistance to traditional therapeutic approaches. N6-methyladenosine (m6A) modification is a prevalent posttranscriptional modification that significantly influences cellular processes by modulating gene expression. However, the role of m6A in the regulation of the DNA damage response (DDR) in GBM cells remains unclear. Through integrated bioinformatics and functional studies, we identified the m6A reader YTHDF3 as a central regulator of the DDR in GBM, and the elevated expression levels of YTHDF3 were correlated with unfavorable clinical outcomes in GBM patients. Human GBM cell lines and patient-derived GBM cells (PDC) models were used to explore the biological function of YTHDF3. Following treatment with temozolomide (TMZ), the level of m6A modification was increased, facilitating YTHDF3-mediated DNA damage repair. The knockdown of METTL3 resulted in a reduction in functional m6A modification and suppressed the expression of DDR core factors, which are mediated by YTHDF3. Mechanistically, YTHDF3 recognizes the m6A binding site of DNA damage response genes (BRCA1, RAD51, RIF1 and 53BP1) and promotes their translation through m6A methylation, thereby initiating homologous recombination (HR) and nonhomologous end joining (NHEJ) repair to resist endogenous and exogenous DNA damage. Consequently, our study elucidates the crucial role of YTHDF3 in GBM and provides valuable insights into its significance in the DNA damage response and chemoresistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaRNA-Binding ProteinsMethyltransferasesDrug Resistance, NeoplasmAdenosineDNA DamageBrain NeoplasmsHumansCell Line, TumorTemozolomideRNA MethylationGene Expression Regulation, NeoplasticAnimalsDNA RepairMiceAntineoplastic Agents, Alkylating

Stichwörter der Autor:innen

DNA damage responseGlioblastomaN6-methyladenosineTemozolomideYTHDF3

Substanzen

RNA-Binding ProteinsMethyltransferasesMETTL3 protein, humanAdenosineTemozolomideYTHDF3 protein, humanN-methyladenosineAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Department of Neurosurgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.
  • Department of Neurosurgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China; State Key Laboratory of Cardiovascular Diseases and Medical Innovation Center, Shanghai East Hospital,…
  • Department of Neurosurgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China. Electronic address: drchunlongzhong@tongji.edu.cn.

Förderung

  • Shanghai Key Discipline Construction Project
  • Natural Science Foundation of Shanghai Municipality
  • Shanghai Municipal Health Commission
  • National Natural Science Foundation of China
  • Shanghai Pudong New Area Health Commission

Zitieren

APA

Cheng, M., Pang, Y., Wang, R., Chen, X., Zhang, C., Yang, Y., Ji, T., Wu, Y., Wang, J., Xu, S., Wang, Z., Liu, M., Zhang, J., & Zhong, C. (2026). YTHDF3 facilitates DNA damage response by recognizing METTL3-mediated m6A modification to promote chemotherapy resistance in glioblastoma. Cancer Letters, 649, 218445. https://doi.org/10.1016/j.canlet.2026.218445

Vancouver

Cheng M, Pang Y, Wang R, Chen X, Zhang C, Yang Y, et al. YTHDF3 facilitates DNA damage response by recognizing METTL3-mediated m6A modification to promote chemotherapy resistance in glioblastoma. Cancer Letters. 2026;649:218445. doi:10.1016/j.canlet.2026.218445

BibTeX
@article{Cheng2026,
  author = {Cheng, Meng and Pang, Ying and Wang, Rui and Chen, Xu and Zhang, Chunyu and Yang, Yuntong and Ji, Tongjie and Wu, Yueyao and Wang, Jingzhe and Xu, Siyi and Wang, Zhigang and Liu, Min and Zhang, Jing and Zhong, Chunlong},
  title = {YTHDF3 facilitates DNA damage response by recognizing METTL3-mediated m6A modification to promote chemotherapy resistance in glioblastoma},
  journal = {Cancer Letters},
  year = {2026},
  volume = {649},
  pages = {218445},
  doi = {10.1016/j.canlet.2026.218445}
}
Kostenlos starten →